Ascendis Pharma A ASND
NASDAQ ASND
$228.07 -1.98 (-0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Convertible Debt (2021 - 2026)

Updated

Ascendis Pharma A (ASND) reported Convertible Debt of $206.81 million for the quarter ended Mar 31, 2026, up 105.3% from $100.74 million a year earlier but down 58.6% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Convertible Debt (2021 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A posted Convertible Debt of $485.13 million, up 352.1% from the prior year.

  • Convertible Debt has increased for four consecutive years, with a four-year compound annual growth rate of 334.2% (years ended Dec 2021 to Dec 2025).
  • By year, Convertible Debt came in at $107.31 million in the year ended Dec 31, 2024 (+203.2%), $35.39 million in the year ended Dec 31, 2023 (+357.6%), $7.73 million in the year ended Dec 31, 2022 (+466.8%) and $1.36 million in the year ended Dec 31, 2021.
  • Five-year quarterly Convertible Debt spans a low of $1.36 million in the quarter ended Dec 31, 2021 and a high of $499.83 million in the quarter ended Dec 31, 2025.
  • Year over year, Convertible Debt has now increased in each of the last 14 quarters, with growth averaging 270.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Convertible Debt ran from 46.3% in the quarter ended Sep 30, 2025 to 876.7% in the quarter ended Jun 30, 2024.
  • Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $499.83 million (quarter ended Dec 31, 2025), $161.07 million (quarter ended Sep 30, 2025) and $169.72 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Ascendis Pharma A 14.26 Bn 10.50 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 206.81 Mn
Dec 31, 2025 499.83 Mn
Sep 30, 2025 161.07 Mn
Jun 30, 2025 169.72 Mn
Mar 31, 2025 100.74 Mn
Dec 31, 2024 105.95 Mn
Sep 30, 2024 110.12 Mn
Jun 30, 2024 114.98 Mn
Mar 31, 2024 44.05 Mn
Dec 31, 2023 35.20 Mn
Sep 30, 2023 22.62 Mn
Jun 30, 2023 11.77 Mn
Mar 31, 2023 9.83 Mn
Dec 31, 2022 7.49 Mn
Sep 30, 2022 6.86 Mn
Jun 30, 2022 5.35 Mn
Mar 31, 2022 2.75 Mn
Dec 31, 2021 1.36 Mn
API Access

Ascendis Pharma A Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ASND&period=max&api_key=YOUR_API_KEY